The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
2016 · Scientific Reports · 81 citations
https://doi.org/10.1038/srep32463
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
1.7K
Citations
25
h-index
34
i10-index
Yu‐Chang Chen is an academic researcher from Kaohsiung Medical University. The author has contributed to research in topics: Traditional and Medicinal Uses of Annonaceae & Natural product bioactivities and synthesis & Phytochemistry and Biological Activities. The author has an h-index of 25, co-authored 58 publications.
ORCID: 0000-0001-6000-6306https://doi.org/10.1038/srep32463
https://doi.org/10.1016/j.scr.2017.06.002
Click to start Chat